Details for New Drug Application (NDA): 080854
✉ Email this page to a colleague
NDA 080854 describes HEXA-BETALIN, which is a drug marketed by Lilly and is included in one NDA. Additional details are available on the HEXA-BETALIN profile page.
The generic ingredient in HEXA-BETALIN is pyridoxine hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pyridoxine hydrochloride profile page.
The generic ingredient in HEXA-BETALIN is pyridoxine hydrochloride. There are four drug master file entries for this compound. Two suppliers are listed for this compound. Additional details are available on the pyridoxine hydrochloride profile page.
Summary for 080854
| Tradename: | HEXA-BETALIN |
| Applicant: | Lilly |
| Ingredient: | pyridoxine hydrochloride |
| Patents: | 0 |
Medical Subject Heading (MeSH) Categories for 080854
Profile for product number 001
| Active Rx/OTC/Discontinued: | DISCN | Dosage: | INJECTABLE;INJECTION | Strength | 100MG/ML | ||||
| Approval Date: | Approved Prior to Jan 1, 1982 | TE: | RLD: | No | |||||
Complete Access Available with Subscription
